ID   DHB1_HUMAN              Reviewed;         328 AA.
AC   P14061; B3KXS1; Q2M2L8;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 3.
DT   07-APR-2021, entry version 216.
DE   RecName: Full=17-beta-hydroxysteroid dehydrogenase type 1 {ECO:0000305};
DE            Short=17-beta-HSD 1;
DE            EC=1.1.1.51 {ECO:0000250|UniProtKB:P51656};
DE   AltName: Full=20 alpha-hydroxysteroid dehydrogenase;
DE            Short=20-alpha-HSD;
DE   AltName: Full=E2DH;
DE   AltName: Full=Estradiol 17-beta-dehydrogenase 1 {ECO:0000305};
DE            EC=1.1.1.62 {ECO:0000269|PubMed:8994190};
DE   AltName: Full=Placental 17-beta-hydroxysteroid dehydrogenase;
DE   AltName: Full=Short chain dehydrogenase/reductase family 28C member 1;
GN   Name=HSD17B1 {ECO:0000312|HGNC:HGNC:5210};
GN   Synonyms=E17KSR, EDH17B1, EDH17B2, EDHB17, SDR28C1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-313.
RC   TISSUE=Placenta;
RX   PubMed=2846351; DOI=10.1016/0014-5793(88)80548-9;
RA   Peltoketo H., Isomaa V., Maeentausta O., Vihko R.;
RT   "Complete amino acid sequence of human placental 17 beta-hydroxysteroid
RT   dehydrogenase deduced from cDNA.";
RL   FEBS Lett. 239:73-77(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-313.
RC   TISSUE=Placenta;
RX   PubMed=2779584; DOI=10.1210/mend-3-8-1301;
RA   Luu-The V., Labrie C., Zhao H.F., Couet J., Lachance Y., Simard J.,
RA   Leblanc G., Labrie F.;
RT   "Characterization of cDNAs for human estradiol 17 beta-dehydrogenase and
RT   assignment of the gene to chromosome 17: evidence of two mRNA species with
RT   distinct 5'-termini in human placenta.";
RL   Mol. Endocrinol. 3:1301-1309(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-313.
RX   PubMed=2330005; DOI=10.1210/mend-4-2-268;
RA   Luu-The V., Labrie C., Simard J., Lachance Y., Zhao H.F., Couet J.,
RA   Leblanc G., Labrie F.;
RT   "Structure of two in tandem human 17 beta-hydroxysteroid dehydrogenase
RT   genes.";
RL   Mol. Endocrinol. 4:268-275(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-313.
RX   PubMed=2197970; DOI=10.1111/j.1749-6632.1990.tb34281.x;
RA   Luu-The V., Labrie C., Zhao H.F., Couet J., Lachance Y., Simard J.,
RA   Cote J., Leblanc G., Lagace L., Berube D., Gagne R., Labrie F.;
RT   "Purification, cloning, complementary DNA structure, and predicted amino
RT   acid sequence of human estradiol 17 beta-dehydrogenase.";
RL   Ann. N. Y. Acad. Sci. 595:40-52(1990).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-313.
RX   PubMed=1327779; DOI=10.1111/j.1432-1033.1992.tb17310.x;
RA   Peltoketo H.E., Isomma V., Vihko R.;
RT   "Genomic organization and DNA sequences of human 17 beta-hydroxysteroid
RT   dehydrogenase genes and flanking regions. Localization of multiple Alu
RT   sequences and putative cis-acting elements.";
RL   Eur. J. Biochem. 209:459-466(1992).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-313.
RA   Shen Y., Gibbs R.A.;
RL   Submitted (SEP-1995) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-313.
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT SER-313.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-313.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   PROTEIN SEQUENCE OF 2-6.
RX   PubMed=5045524; DOI=10.1021/bi00764a023;
RA   Burns D.J.W., Engel L.L., Bethune J.L.;
RT   "Amino acid composition and subunit structure. Human placental 17
RT   - estradiol dehydrogenase.";
RL   Biochemistry 11:2699-2703(1972).
RN   [12]
RP   PROTEIN SEQUENCE OF 52-68.
RX   PubMed=4719204; DOI=10.1016/0014-5793(73)80554-x;
RA   Nicholas J.C., Harris J.I.;
RT   "Human placental 17 -oestradiol dehydrogenase. Sequence of a tryptic
RT   peptide containing an essential cysteine.";
RL   FEBS Lett. 29:173-176(1973).
RN   [13]
RP   PROTEIN SEQUENCE OF 205-224.
RX   PubMed=3456799; DOI=10.1021/bi00351a019;
RA   Murdock G.L., Chin C.-C., Warren J.C.;
RT   "Human placental estradiol 17 beta-dehydrogenase: sequence of a histidine-
RT   bearing peptide in the catalytic region.";
RL   Biochemistry 25:641-646(1986).
RN   [14]
RP   PROTEIN SEQUENCE OF 220-224.
RX   PubMed=6578212;
RA   Murdock G.L., Chin C.C., Offord R.E., Bradshaw R.A., Warren J.C.;
RT   "Human placental estradiol 17 beta-dehydrogenase. Identification of a
RT   single histidine residue affinity-labeled by both 3-bromoacetoxyestrone and
RT   12 beta-bromoacetoxy-4-estrene-3,17-dione.";
RL   J. Biol. Chem. 258:11460-11464(1983).
RN   [15]
RP   SIMILARITY TO SHORT CHAIN DEHYDROGENASES.
RX   PubMed=2547159; DOI=10.1210/mend-3-5-881;
RA   Baker M.E.;
RT   "Human placental 17 beta-hydroxysteroid dehydrogenase is homologous to NodG
RT   protein of Rhizobium meliloti.";
RL   Mol. Endocrinol. 3:881-884(1989).
RN   [16]
RP   FUNCTION, SUBUNIT, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES,
RP   MUTAGENESIS OF 112-LEU--VAL-114; SER-135; SER-143; TYR-156; LYS-160;
RP   ALA-171; HIS-222 AND GLU-283, AND PHOSPHORYLATION AT SER-135.
RX   PubMed=8994190; DOI=10.1210/mend.11.1.9872;
RA   Puranen T., Poutanen M., Ghosh D., Vihko P., Vihko R.;
RT   "Characterization of structural and functional properties of human 17 beta-
RT   hydroxysteroid dehydrogenase type 1 using recombinant enzymes and site-
RT   directed mutagenesis.";
RL   Mol. Endocrinol. 11:77-86(1997).
RN   [17] {ECO:0007744|PDB:1BHS}
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS).
RX   PubMed=7663947; DOI=10.1016/s0969-2126(01)00183-6;
RA   Ghosh D., Pletnev V.Z., Zhu D.W., Wawrzak Z., Duax W.L., Pangborn W.,
RA   Labrie F., Lin S.-X.;
RT   "Structure of human estrogenic 17 beta-hydroxysteroid dehydrogenase at
RT   2.20-A resolution.";
RL   Structure 3:503-513(1995).
RN   [18] {ECO:0007744|PDB:1IOL}
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS).
RX   PubMed=8756321; DOI=10.1038/nsb0896-665;
RA   Azzi A., Rehse P.H., Zhu D.W., Campbell R.L., Labrie F., Lin S.X.;
RT   "Crystal structure of human estrogenic 17 beta-hydroxysteroid dehydrogenase
RT   complexed with 17 beta-estradiol.";
RL   Nat. Struct. Biol. 3:665-668(1996).
RN   [19] {ECO:0007744|PDB:1FDS, ECO:0007744|PDB:1FDT}
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) IN COMPLEX WITH SUBSTRATE AND NADP.
RX   PubMed=8805577; DOI=10.1016/s0969-2126(96)00098-6;
RA   Breton R., Housset D., Mazza C., Fontecilla-Camps J.-C.;
RT   "The structure of a complex of human 17beta-hydroxysteroid dehydrogenase
RT   with estradiol and NADP+ identifies two principal targets for the design of
RT   inhibitors.";
RL   Structure 4:905-915(1996).
RN   [20] {ECO:0007744|PDB:1FDU, ECO:0007744|PDB:1FDV, ECO:0007744|PDB:1FDW}
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS).
RX   PubMed=9525918; DOI=10.1074/jbc.273.14.8145;
RA   Mazza C., Breton R., Housset D., Fontecilla-Camps J.-C.;
RT   "Unusual charge stabilization of NADP+ in 17beta-hydroxysteroid
RT   dehydrogenase.";
RL   J. Biol. Chem. 273:8145-8152(1998).
RN   [21] {ECO:0007744|PDB:1EQU}
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS).
RX   PubMed=9927655; DOI=10.1073/pnas.96.3.840;
RA   Sawicki M.W., Erman M., Puranen T., Vihko P., Ghosh D.;
RT   "Structure of the ternary complex of human 17beta-hydroxysteroid
RT   dehydrogenase type 1 with 3-hydroxyestra-1,3,5,7-tetraen-17-one (equilin)
RT   and NADP+.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:840-845(1999).
RN   [22] {ECO:0007744|PDB:1DHT, ECO:0007744|PDB:3DHE}
RP   X-RAY CRYSTALLOGRAPHY (2.24 ANGSTROMS) OF 39-328, AND MUTAGENESIS OF
RP   LEU-150.
RX   PubMed=10625652; DOI=10.1074/jbc.275.2.1105;
RA   Han Q., Campbell R.L., Gangloff A., Huang Y.-W., Lin S.-X.;
RT   "Dehydroepiandrosterone and dihydrotestosterone recognition by human
RT   estrogenic 17beta-hydroxysteroid dehydrogenase. C-18/c-19 steroid
RT   discrimination and enzyme-induced strain.";
RL   J. Biol. Chem. 275:1105-1111(2000).
RN   [23] {ECO:0007744|PDB:1I5R}
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS).
RX   PubMed=12223444; DOI=10.1096/fj.02-0026fje;
RA   Qiu W., Campbell R.L., Gangloff A., Dupuis P., Boivin R.P., Tremblay M.R.,
RA   Poirier D., Lin S.X.;
RT   "A concerted, rational design of type 1 17beta-hydroxysteroid dehydrogenase
RT   inhibitors: estradiol-adenosine hybrids with high affinity.";
RL   FASEB J. 16:1829-1831(2002).
RN   [24] {ECO:0007744|PDB:1JTV}
RP   X-RAY CRYSTALLOGRAPHY (1.54 ANGSTROMS).
RX   PubMed=12490543; DOI=10.1096/fj.02-0397fje;
RA   Gangloff A., Shi R., Nahoum V., Lin S.X.;
RT   "Pseudo-symmetry of C19 steroids, alternative binding orientations, and
RT   multispecificity in human estrogenic 17beta-hydroxysteroid dehydrogenase.";
RL   FASEB J. 17:274-276(2003).
RN   [25] {ECO:0007744|PDB:1QYV, ECO:0007744|PDB:1QYW, ECO:0007744|PDB:1QYX}
RP   X-RAY CRYSTALLOGRAPHY (1.81 ANGSTROMS).
RX   PubMed=14966133; DOI=10.1074/jbc.m313156200;
RA   Shi R., Lin S.X.;
RT   "Cofactor hydrogen bonding onto the protein main chain is conserved in the
RT   short chain dehydrogenase/reductase family and contributes to nicotinamide
RT   orientation.";
RL   J. Biol. Chem. 279:16778-16785(2004).
RN   [26]
RP   VARIANTS VAL-238 AND SER-313.
RX   PubMed=8389226; DOI=10.1093/hmg/2.4.479;
RA   Normand T., Narod S., Labrie F., Simard J.;
RT   "Detection of polymorphisms in the estradiol 17 beta-hydroxysteroid
RT   dehydrogenase II gene at the EDH17B2 locus on 17q11-q21.";
RL   Hum. Mol. Genet. 2:479-483(1993).
CC   -!- FUNCTION: Favors the reduction of estrogens and androgens. Converts
CC       estrone (E1) to a more potent estrogen, 17beta-estradiol (E2)
CC       (PubMed:8994190). Also has 20-alpha-HSD activity. Uses preferentially
CC       NADH. {ECO:0000269|PubMed:8994190}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17beta-estradiol + NAD(+) = estrone + H(+) + NADH;
CC         Xref=Rhea:RHEA:24612, ChEBI:CHEBI:15378, ChEBI:CHEBI:16469,
CC         ChEBI:CHEBI:17263, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.1.1.62;
CC         Evidence={ECO:0000269|PubMed:8994190};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17beta-estradiol + NADP(+) = estrone + H(+) + NADPH;
CC         Xref=Rhea:RHEA:24616, ChEBI:CHEBI:15378, ChEBI:CHEBI:16469,
CC         ChEBI:CHEBI:17263, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.1.1.62;
CC         Evidence={ECO:0000250|UniProtKB:P51656};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:24618;
CC         Evidence={ECO:0000250|UniProtKB:P51656};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NADP(+) + testosterone = androst-4-ene-3,17-dione + H(+) +
CC         NADPH; Xref=Rhea:RHEA:14981, ChEBI:CHEBI:15378, ChEBI:CHEBI:16422,
CC         ChEBI:CHEBI:17347, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.1.1.51;
CC         Evidence={ECO:0000250|UniProtKB:P51656};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:14983;
CC         Evidence={ECO:0000250|UniProtKB:P51656};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.11 uM for 17beta-estradiol {ECO:0000269|PubMed:8994190};
CC         KM=0.9 uM for estrone {ECO:0000269|PubMed:8994190};
CC   -!- PATHWAY: Steroid biosynthesis; estrogen biosynthesis.
CC       {ECO:0000269|PubMed:8994190}.
CC   -!- SUBUNIT: Homodimer. Exists predominantly as an homodimer but also exits
CC       as monomer. {ECO:0000269|PubMed:8805577, ECO:0000269|PubMed:8994190}.
CC   -!- INTERACTION:
CC       P14061; P09917: ALOX5; NbExp=3; IntAct=EBI-12867244, EBI-79934;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases (SDR)
CC       family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=HSD17B1";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X13440; CAA31792.1; -; mRNA.
DR   EMBL; M36263; AAA35600.1; -; mRNA.
DR   EMBL; M27138; AAB16941.1; -; Genomic_DNA.
DR   EMBL; M84472; AAB16942.1; -; Genomic_DNA.
DR   EMBL; U34879; AAD05019.1; -; Genomic_DNA.
DR   EMBL; AK127832; BAG54583.1; -; mRNA.
DR   EMBL; AC067852; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471152; EAW60836.1; -; Genomic_DNA.
DR   EMBL; BC104752; AAI04753.1; -; mRNA.
DR   EMBL; BC111935; AAI11936.1; -; mRNA.
DR   CCDS; CCDS11428.1; -.
DR   PIR; A36081; DEHUE7.
DR   RefSeq; NP_000404.2; NM_000413.3.
DR   PDB; 1A27; X-ray; 1.90 A; A=2-290.
DR   PDB; 1BHS; X-ray; 2.20 A; A=2-328.
DR   PDB; 1DHT; X-ray; 2.24 A; A=2-328.
DR   PDB; 1EQU; X-ray; 3.00 A; A/B=2-328.
DR   PDB; 1FDS; X-ray; 1.70 A; A=2-328.
DR   PDB; 1FDT; X-ray; 2.20 A; A=2-328.
DR   PDB; 1FDU; X-ray; 2.70 A; A/B/C/D=2-328.
DR   PDB; 1FDV; X-ray; 3.10 A; A/B/C/D=2-328.
DR   PDB; 1FDW; X-ray; 2.70 A; A=2-328.
DR   PDB; 1I5R; X-ray; 1.60 A; A=2-328.
DR   PDB; 1IOL; X-ray; 2.30 A; A=2-328.
DR   PDB; 1JTV; X-ray; 1.54 A; A=2-328.
DR   PDB; 1QYV; X-ray; 1.81 A; A=2-328.
DR   PDB; 1QYW; X-ray; 1.63 A; A=2-328.
DR   PDB; 1QYX; X-ray; 1.89 A; A=2-328.
DR   PDB; 3DEY; X-ray; 1.70 A; X=2-328.
DR   PDB; 3DHE; X-ray; 2.30 A; A=2-328.
DR   PDB; 3HB4; X-ray; 2.21 A; X=2-328.
DR   PDB; 3HB5; X-ray; 2.00 A; X=2-328.
DR   PDB; 3KLM; X-ray; 1.70 A; X=2-328.
DR   PDB; 3KLP; X-ray; 2.50 A; X=2-328.
DR   PDB; 3KM0; X-ray; 2.30 A; A/B=2-328.
DR   PDB; 6CGC; X-ray; 2.10 A; A/B=1-328.
DR   PDB; 6CGE; X-ray; 2.20 A; A/B=1-328.
DR   PDB; 6DTP; X-ray; 2.00 A; A/B=1-328.
DR   PDB; 6MNC; X-ray; 2.40 A; A/B=1-328.
DR   PDB; 6MNE; X-ray; 1.86 A; A/B=1-328.
DR   PDBsum; 1A27; -.
DR   PDBsum; 1BHS; -.
DR   PDBsum; 1DHT; -.
DR   PDBsum; 1EQU; -.
DR   PDBsum; 1FDS; -.
DR   PDBsum; 1FDT; -.
DR   PDBsum; 1FDU; -.
DR   PDBsum; 1FDV; -.
DR   PDBsum; 1FDW; -.
DR   PDBsum; 1I5R; -.
DR   PDBsum; 1IOL; -.
DR   PDBsum; 1JTV; -.
DR   PDBsum; 1QYV; -.
DR   PDBsum; 1QYW; -.
DR   PDBsum; 1QYX; -.
DR   PDBsum; 3DEY; -.
DR   PDBsum; 3DHE; -.
DR   PDBsum; 3HB4; -.
DR   PDBsum; 3HB5; -.
DR   PDBsum; 3KLM; -.
DR   PDBsum; 3KLP; -.
DR   PDBsum; 3KM0; -.
DR   PDBsum; 6CGC; -.
DR   PDBsum; 6CGE; -.
DR   PDBsum; 6DTP; -.
DR   PDBsum; 6MNC; -.
DR   PDBsum; 6MNE; -.
DR   SMR; P14061; -.
DR   BioGRID; 109525; 16.
DR   IntAct; P14061; 2.
DR   STRING; 9606.ENSP00000466799; -.
DR   BindingDB; P14061; -.
DR   ChEMBL; CHEMBL3181; -.
DR   DrugBank; DB01561; Androstanedione.
DR   DrugBank; DB01536; Androstenedione.
DR   DrugBank; DB02323; EM-1745.
DR   DrugBank; DB02187; Equilin.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB03461; Nicotinamide adenine dinucleotide phosphate.
DR   DrugBank; DB01708; Prasterone.
DR   DrugBank; DB02901; Stanolone.
DR   DrugBank; DB13951; Stanolone acetate.
DR   DrugCentral; P14061; -.
DR   SwissLipids; SLP:000001218; -.
DR   SwissPalm; P14061; -.
DR   BioMuta; HSD17B1; -.
DR   DMDM; 313104233; -.
DR   jPOST; P14061; -.
DR   MassIVE; P14061; -.
DR   PaxDb; P14061; -.
DR   PeptideAtlas; P14061; -.
DR   PRIDE; P14061; -.
DR   ProteomicsDB; 53018; -.
DR   Antibodypedia; 16966; 293 antibodies.
DR   Ensembl; ENST00000585807; ENSP00000466799; ENSG00000108786.
DR   GeneID; 3292; -.
DR   KEGG; hsa:3292; -.
DR   UCSC; uc002hzw.4; human.
DR   CTD; 3292; -.
DR   DisGeNET; 3292; -.
DR   GeneCards; HSD17B1; -.
DR   HGNC; HGNC:5210; HSD17B1.
DR   HPA; ENSG00000108786; Tissue enriched (placenta).
DR   MIM; 109684; gene.
DR   neXtProt; NX_P14061; -.
DR   OpenTargets; ENSG00000108786; -.
DR   PharmGKB; PA29478; -.
DR   VEuPathDB; HostDB:ENSG00000108786.10; -.
DR   eggNOG; KOG1205; Eukaryota.
DR   GeneTree; ENSGT00940000160415; -.
DR   HOGENOM; CLU_010194_2_9_1; -.
DR   InParanoid; P14061; -.
DR   PhylomeDB; P14061; -.
DR   BRENDA; 1.1.1.62; 2681.
DR   PathwayCommons; P14061; -.
DR   Reactome; R-HSA-193144; Estrogen biosynthesis.
DR   Reactome; R-HSA-2453902; The canonical retinoid cycle in rods (twilight vision).
DR   SABIO-RK; P14061; -.
DR   UniPathway; UPA00769; -.
DR   BioGRID-ORCS; 3292; 3 hits in 996 CRISPR screens.
DR   ChiTaRS; HSD17B1; human.
DR   EvolutionaryTrace; P14061; -.
DR   GeneWiki; HSD17B1; -.
DR   GenomeRNAi; 3292; -.
DR   Pharos; P14061; Tchem.
DR   PRO; PR:P14061; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; P14061; protein.
DR   Bgee; ENSG00000108786; Expressed in chorionic villus and 139 other tissues.
DR   ExpressionAtlas; P14061; baseline and differential.
DR   Genevisible; P14061; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0044594; F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; IEA:RHEA.
DR   GO; GO:0072582; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; ISS:UniProtKB.
DR   GO; GO:0003824; F:catalytic activity; TAS:ProtInc.
DR   GO; GO:0035410; F:dihydrotestosterone 17-beta-dehydrogenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004303; F:estradiol 17-beta-dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:1903924; F:estradiol binding; IDA:CAFA.
DR   GO; GO:0050661; F:NADP binding; IDA:UniProtKB.
DR   GO; GO:0070401; F:NADP+ binding; IMP:CAFA.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0005496; F:steroid binding; IDA:CAFA.
DR   GO; GO:0047045; F:testosterone 17-beta-dehydrogenase (NADP+) activity; IEA:RHEA.
DR   GO; GO:0030283; F:testosterone dehydrogenase [NAD(P)] activity; ISS:UniProtKB.
DR   GO; GO:0006703; P:estrogen biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0008210; P:estrogen metabolic process; TAS:ProtInc.
DR   GO; GO:0006694; P:steroid biosynthetic process; TAS:ProtInc.
DR   GO; GO:0061370; P:testosterone biosynthetic process; ISS:UniProtKB.
DR   DisProt; DP00023; -.
DR   InterPro; IPR011348; 17beta_DH.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR   InterPro; IPR002347; SDR_fam.
DR   Pfam; PF00106; adh_short; 1.
DR   PIRSF; PIRSF000095; 17beta-HSD; 1.
DR   PRINTS; PR00081; GDHRDH.
DR   PRINTS; PR00080; SDRFAMILY.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS00061; ADH_SHORT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Direct protein sequencing; Lipid biosynthesis;
KW   Lipid metabolism; NADP; Oxidoreductase; Phosphoprotein; Reference proteome;
KW   Steroid biosynthesis.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:5045524"
FT   CHAIN           2..328
FT                   /note="17-beta-hydroxysteroid dehydrogenase type 1"
FT                   /id="PRO_0000054567"
FT   NP_BIND         10..38
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:8805577"
FT   ACT_SITE        156
FT                   /note="Proton acceptor"
FT   BINDING         66
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:8805577"
FT   BINDING         143
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:8805577"
FT   BINDING         160
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:8805577"
FT   MOD_RES         135
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000269|PubMed:8994190"
FT   VARIANT         238
FT                   /note="A -> V (in dbSNP:rs147402365)"
FT                   /evidence="ECO:0000269|PubMed:8389226"
FT                   /id="VAR_006951"
FT   VARIANT         313
FT                   /note="G -> S (in dbSNP:rs605059)"
FT                   /evidence="ECO:0000269|PubMed:1327779,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:2197970, ECO:0000269|PubMed:2330005,
FT                   ECO:0000269|PubMed:2779584, ECO:0000269|PubMed:2846351,
FT                   ECO:0000269|PubMed:8389226, ECO:0000269|Ref.6,
FT                   ECO:0000269|Ref.9"
FT                   /id="VAR_006952"
FT   MUTAGEN         112..114
FT                   /note="LDV->F: Loss of 17-beta-hydroxysteroid dehydrogenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:8994190"
FT   MUTAGEN         135
FT                   /note="S->A: Abolishes phosphorylation. No effect on 17-
FT                   beta-hydroxysteroid dehydrogenase activity."
FT                   /evidence="ECO:0000269|PubMed:8994190"
FT   MUTAGEN         143
FT                   /note="S->A: Loss of 17-beta-hydroxysteroid dehydrogenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:8994190"
FT   MUTAGEN         150
FT                   /note="L->V: Alters substrate specificity."
FT                   /evidence="ECO:0000269|PubMed:10625652"
FT   MUTAGEN         156
FT                   /note="Y->A: Loss of 17-beta-hydroxysteroid dehydrogenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:8994190"
FT   MUTAGEN         160
FT                   /note="K->A: Loss of 17-beta-hydroxysteroid dehydrogenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:8994190"
FT   MUTAGEN         171
FT                   /note="A->AEF: Loss of 17-beta-hydroxysteroid dehydrogenase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:8994190"
FT   MUTAGEN         222
FT                   /note="H->A: No effect on conversion of estrone to 17beta-
FT                   estradiol."
FT                   /evidence="ECO:0000269|PubMed:8994190"
FT   MUTAGEN         283
FT                   /note="E->A: No effect on conversion of estrone to 17beta-
FT                   estradiol."
FT                   /evidence="ECO:0000269|PubMed:8994190"
FT   MUTAGEN         283
FT                   /note="E->Q: No effect on conversion of estrone to 17beta-
FT                   estradiol."
FT                   /evidence="ECO:0000269|PubMed:8994190"
FT   CONFLICT        3
FT                   /note="R -> E (in Ref. 11; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   STRAND          4..9
FT                   /evidence="ECO:0007744|PDB:1JTV"
FT   HELIX           14..24
FT                   /evidence="ECO:0007744|PDB:1JTV"
FT   STRAND          31..38
FT                   /evidence="ECO:0007744|PDB:1JTV"
FT   HELIX           40..42
FT                   /evidence="ECO:0007744|PDB:1JTV"
FT   HELIX           44..52
FT                   /evidence="ECO:0007744|PDB:1JTV"
FT   STRAND          59..64
FT                   /evidence="ECO:0007744|PDB:1JTV"
FT   HELIX           70..78
FT                   /evidence="ECO:0007744|PDB:1JTV"
FT   STRAND          86..90
FT                   /evidence="ECO:0007744|PDB:1JTV"
FT   HELIX           100..102
FT                   /evidence="ECO:0007744|PDB:1JTV"
FT   HELIX           105..115
FT                   /evidence="ECO:0007744|PDB:1JTV"
FT   HELIX           117..133
FT                   /evidence="ECO:0007744|PDB:1JTV"
FT   STRAND          136..143
FT                   /evidence="ECO:0007744|PDB:1JTV"
FT   HELIX           144..146
FT                   /evidence="ECO:0007744|PDB:1JTV"
FT   HELIX           154..174
FT                   /evidence="ECO:0007744|PDB:1JTV"
FT   HELIX           175..177
FT                   /evidence="ECO:0007744|PDB:1JTV"
FT   STRAND          179..186
FT                   /evidence="ECO:0007744|PDB:1JTV"
FT   STRAND          189..192
FT                   /evidence="ECO:0007744|PDB:1A27"
FT   TURN            193..196
FT                   /evidence="ECO:0007744|PDB:1A27"
FT   HELIX           201..206
FT                   /evidence="ECO:0007744|PDB:1JTV"
FT   HELIX           210..230
FT                   /evidence="ECO:0007744|PDB:1JTV"
FT   HELIX           234..246
FT                   /evidence="ECO:0007744|PDB:1JTV"
FT   STRAND          252..256
FT                   /evidence="ECO:0007744|PDB:1JTV"
FT   STRAND          258..260
FT                   /evidence="ECO:0007744|PDB:1EQU"
FT   HELIX           261..269
FT                   /evidence="ECO:0007744|PDB:1JTV"
FT   HELIX           274..285
FT                   /evidence="ECO:0007744|PDB:1JTV"
SQ   SEQUENCE   328 AA;  34950 MW;  5B5C8909F9120832 CRC64;
     MARTVVLITG CSSGIGLHLA VRLASDPSQS FKVYATLRDL KTQGRLWEAA RALACPPGSL
     ETLQLDVRDS KSVAAARERV TEGRVDVLVC NAGLGLLGPL EALGEDAVAS VLDVNVVGTV
     RMLQAFLPDM KRRGSGRVLV TGSVGGLMGL PFNDVYCASK FALEGLCESL AVLLLPFGVH
     LSLIECGPVH TAFMEKVLGS PEEVLDRTDI HTFHRFYQYL AHSKQVFREA AQNPEEVAEV
     FLTALRAPKP TLRYFTTERF LPLLRMRLDD PSGSNYVTAM HREVFGDVPA KAEAGAEAGG
     GAGPGAEDEA GRGAVGDPEL GDPPAAPQ
//
